{"transactions":[{"id":2223049,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":125911,"kind":"organization","name":"Quaker BioVentures II LP","position":1,"cik":"0001497725","reported_name":"Quaker BioVentures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125912,"kind":"organization","name":"Quaker BioVentures Capital II, L.P.","position":2,"cik":"0001583083","reported_name":"Quaker BioVentures Capital II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-23T06:30:46.000Z","date":"2022-06-02","kind":"other","acquired":false,"shares":1751100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Quaker BioVentures II, L.P. distributed these shares on a pro rata basis, for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Quaker BioVentures Capital II, L.P., the general partner of Quaker BioVentures II, L.P., received its pro rata shares in the distribution and in turn distributed all such shares to its own partners."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-22-073703","document":"tm2219007-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497725/000110465922073703/tm2219007-1_4seq.xml","form_type":"4"}},{"id":3372884,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":125911,"kind":"organization","name":"Quaker BioVentures II LP","position":1,"cik":"0001497725","reported_name":"Quaker BioVentures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125912,"kind":"organization","name":"Quaker BioVentures Capital II, L.P.","position":2,"cik":"0001583083","reported_name":"Quaker BioVentures Capital II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-13T21:03:35.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":446813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":446813,"derivative":{"exercise_price":28.65,"exercise_date":"2019-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":18096},"source":{"system":"sec-edgar","filing":"0001192482-19-000430","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1497725/000119248219000430/edgar.xml","form_type":"4"}},{"id":3372883,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":125911,"kind":"organization","name":"Quaker BioVentures II LP","position":1,"cik":"0001497725","reported_name":"Quaker BioVentures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125912,"kind":"organization","name":"Quaker BioVentures Capital II, L.P.","position":2,"cik":"0001583083","reported_name":"Quaker BioVentures Capital II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-13T21:03:35.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":446813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":446813},"source":{"system":"sec-edgar","filing":"0001192482-19-000430","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1497725/000119248219000430/edgar.xml","form_type":"4"}},{"id":3372882,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":125911,"kind":"organization","name":"Quaker BioVentures II LP","position":1,"cik":"0001497725","reported_name":"Quaker BioVentures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125912,"kind":"organization","name":"Quaker BioVentures Capital II, L.P.","position":2,"cik":"0001583083","reported_name":"Quaker BioVentures Capital II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-13T21:03:35.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":12763434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":516947},"source":{"system":"sec-edgar","filing":"0001192482-19-000430","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1497725/000119248219000430/edgar.xml","form_type":"4"}},{"id":3372881,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":125911,"kind":"organization","name":"Quaker BioVentures II LP","position":1,"cik":"0001497725","reported_name":"Quaker BioVentures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125912,"kind":"organization","name":"Quaker BioVentures Capital II, L.P.","position":2,"cik":"0001583083","reported_name":"Quaker BioVentures Capital II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-11-13T21:03:35.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":8530145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":345489},"source":{"system":"sec-edgar","filing":"0001192482-19-000430","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1497725/000119248219000430/edgar.xml","form_type":"4"}},{"id":3372880,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":125911,"kind":"organization","name":"Quaker BioVentures II LP","position":1,"cik":"0001497725","reported_name":"Quaker BioVentures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125912,"kind":"organization","name":"Quaker BioVentures Capital II, L.P.","position":2,"cik":"0001583083","reported_name":"Quaker BioVentures Capital II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T21:03:35.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":516947,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":1751100,"source":{"system":"sec-edgar","filing":"0001192482-19-000430","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1497725/000119248219000430/edgar.xml","form_type":"4"}},{"id":3372879,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":125911,"kind":"organization","name":"Quaker BioVentures II LP","position":1,"cik":"0001497725","reported_name":"Quaker BioVentures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125912,"kind":"organization","name":"Quaker BioVentures Capital II, L.P.","position":2,"cik":"0001583083","reported_name":"Quaker BioVentures Capital II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T21:03:35.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":345489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":1234153,"source":{"system":"sec-edgar","filing":"0001192482-19-000430","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497725/000119248219000430/edgar.xml","form_type":"4"}},{"id":3372878,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":125911,"kind":"organization","name":"Quaker BioVentures II LP","position":1,"cik":"0001497725","reported_name":"Quaker BioVentures II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125912,"kind":"organization","name":"Quaker BioVentures Capital II, L.P.","position":2,"cik":"0001583083","reported_name":"Quaker BioVentures Capital II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T21:03:35.000Z","date":"2019-11-08","kind":"purchase","acquired":true,"shares":153846,"price":13,"value":1999998.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 705,530 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":888664,"source":{"system":"sec-edgar","filing":"0001192482-19-000430","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497725/000119248219000430/edgar.xml","form_type":"4"}}]}